• Scientists develop second-generation COVID-19 vaccine taken nasally

    As scientists race to create the next generation of COVID-19 vaccines, this UTMB/CUA research in mice adds new possibilities for fighting the disease in humans in the future. Nasal vaccination induces another type of an immune response which can effectively kill the pathogen at the port of entry, which is the respiratory tract for SARS-CoV-2. No injections are needed, and the vaccine can be delivered in a nasal spray.

  • A profile of a person's face made of jigsaw puzzle pieces with a lightbulb above it and math formulas written in the background.

    Innovation meets entrepreneurship at UTMB

    This summer, the University of Texas Medical Branch and Texas A&M Galveston are teaming up to help students in the field of life sciences propel the good ideas rattling around in their heads into creative solutions that make a real difference in people’s lives.

  • UTMB neurosurgeons perform rare procedure at Clear Lake hospital

    Surgeons at the University of Texas Medical Branch’s Clear Lake Hospital recently combined two different neuroscience procedures to treat a patient’s rare condition. The innovative and life-saving procedure was a first for UTMB.

  • UTMB research links COVID-19 pandemic to poor mental health in adolescents

    A new University of Texas Medical Branch study links COVID-19 restrictions to poor mental health in adolescents. “While it was necessary to prevent the pre-vaccine spread of COVID-19, removing children from school was not without consequences,” said Dr. Jeff Temple, Vice Dean for research at UTMB’s School of Nursing and the director of the Center for Violence Prevention. Temple is the lead author of the study published in the Journal of Adolescent Health.

  • Galveston Healing Arts Orchestra to hold concert

    The Galveston Healing Arts Orchestra will perform a classical concert at 7 p.m. June 24 in the Levin Hall Dining Room on the Galveston campus. The orchestra members include faculty, staff and students at UTMB.

  • Pew selects Baruch as a 2022 Pew Latin American Fellow in Biomedical Sciences

    Pew Charitable Trusts announced that Noe Baruch Torres, Ph.D., a postdoctoral fellow in the department of biochemistry and molecular biology at the University of Texas Medical Branch at Galveston, was selected as a 2022 Pew Latin American Fellows Program in the Biomedical Sciences.

  • UTMB researcher examines why U.S. health continues to lag behind

    Dr. Neil Mehta, an associate professor in epidemiology in the School of Public and Population Health at UTMB, is a guest editor of the special supplemental issue, Why is Health in the United States Continuing to Lag Behind? “There’s no simple answer,” Mehta said. “The issue touches on the many complicated factors with a focus on social and behavioral factors.”

  • UTMB Partners With UT El Paso To Improve Medical Imaging

    The University of Texas Medical Branch partners with UT El Paso on deep learning approach to improving lung region segmentation accuracy in chest x-ray images. The model is one of the first products created in partnership leveraging medical expertise at UTMB and computational expertise with machine learning and artificial intelligence at UT El Paso.

  • An image of a pill capsule full of gears

    UTMB drug discovery partnership awarded $56 million grant

    Thanks to a $56 million grant, the University of Texas Medical Branch and global health care company Novartis will enhance their work together to discover drugs to fight off the next pandemic. The grant comes from the National Institute of Allergy and Infectious Diseases (NIAID) and is one of nine such grants awarded by NIAID to establish Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.